Healthcare investment firm Vivo Capital has announced the final closing of its life science fund, Vivo Opportunity Fund, at an oversubscribed US$635 million, bringing the firm’s total funds under management to over US$2.2 billion. (more…)
Vivo Capital Closes Oversubscribed $635M Life Sciences Fund appeared first on China Money Network.